Skip to main content
Fig. 3 | Acta Neuropathologica Communications

Fig. 3

From: Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohort

Fig. 3

Risk stratification model including the independent parameters residual disease, chromosome 1q gain and mitotic activity. a Venn diagram indicating the frequency of these parameters; b Kaplan-Meier survival analysis shows different outcomes of the patients with standard, intermediate and high risk. Survival was significantly different between all risk groups for EFS and OS (p < 0.001 for all comparisons)

Back to article page
\